HER2 Support Group Forums - Neoadjuvant use of pertuzumab in HER2-positive breast cancer: Hint of lesser benefit

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Neoadjuvant use of pertuzumab in HER2-positive breast cancer: Hint of lesser benefit (https://her2support.org/vbulletin/showthread.php?t=64191)

News	12-04-2015 06:30 AM

Neoadjuvant use of pertuzumab in HER2-positive breast cancer: Hint of lesser benefit

No proof of positive effects, more treatment discontinuations due to side effects.Pertuzumab (trade name: Perjeta) is approved for two therapeutic indications.

More...

All times are GMT -7. The time now is 05:34 PM.